Name | Type | Posted | Actions |
|---|---|---|---|
PWS Attachment 9 - Deliverables FINAL 20260423.pdf | May 11, 2026 | ||
PWS Attachment 8 - Performance Requirements Summary FINAL 20260422.pdf | May 11, 2026 | ||
PWS Attachment 7 - DD Form2875_System Authorization Access Request.pdf | May 11, 2026 | ||
PWS Attachment 6 - Example of DHA Common Training Requirements.pdf | May 11, 2026 | ||
PWS Attachment 5 - Request for Common Access Card.pdf | May 11, 2026 | ||
PWS Attachment 4 - DHA CAC Request Process.pdf | May 11, 2026 | ||
PWS Attachment 3- B2B Gateway Implementation Plan and Questionnaire.pdf | May 11, 2026 | ||
PWS Attachment 2 - DD FORM 1423-1 -System Security Plan.pdf | May 11, 2026 | ||
PWS Attachment 1 - Summary of DoD Sites.pdf | May 11, 2026 | ||
Exhibit E - Subcontractor Teaming Partner Letter and Table.pdf | May 11, 2026 | ||
Exhibit D - Past Performance Questionnaire FINAL.pdf | May 11, 2026 | ||
Exhibit C - Past Performance Summary Sheet FINAL.pdf | May 11, 2026 | ||
Exhibit B - Clinical Reference Laboratory Testing Services QA Matrix FINAL.xlsx | XLSX | May 11, 2026 | |
Exhibit A- Price List_ Schedule of Required Tests FINAL.xlsx | XLSX | May 11, 2026 | |
Attachment 3 - Addendum to FAR 52.212-2 FINAL 20260422.pdf | May 11, 2026 | ||
Attachment 2 - Addendum to FAR 52.212-1 FINAL 20260506.pdf | May 11, 2026 | ||
Attachment 1 - Performance Work Statement (PWS) CRLTS - FINAL 20260419.pdf | May 11, 2026 | ||
RFP - HT001526RE001.pdf | May 11, 2026 |
Clinical Reference Laboratory Testing Services
The Department of Defense, Defense Health Agency (DHA) Enterprise Medical Support office, is soliciting clinical reference laboratory testing services under solicitation HT001526RE001FINAL. This requirement provides approximately 6,960 specialized medical tests that the government cannot perform internally for approximately 205 Military Treatment Facilities globally. The contractor must maintain a secure, bidirectional electronic interface between a commercial laboratory information system and the MHS Genesis electronic health record while meeting Department of Defense cybersecurity requirements, including NIST SP 800-171 and CMMC 2.0. This effort is a follow-on to services currently provided by LabCorp Inc. under contract W81K04-21-D-0001.
This acquisition is a full and open competition resulting in a single-award indefinite delivery/indefinite quantity contract. The performance period includes a five-year base ordering period and a five-year optional ordering period for a potential total of 10 years. Task orders will be issued as firm-fixed-price or through government purchase card orders. The source selection process utilizes a performance price tradeoff where non-price factors, including technical capability, performance risk, and small business subcontracting participation, are significantly more important than price.
The solicitation is classified under NAICS 621511 Medical Laboratories and PSC Q301 Medical- Laboratory Testing. There is no set-aside for this requirement. Responses are due by June 1, 2026, and the primary point of contact is Tamara Fenwick. The solicitation includes 18 attachments such as the performance work statement, price lists, and various security and administrative forms. Performance will take place across the United States.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
Tamara Fenwick
USA
1. INTRODUCTION The Defense Health Agency (DHA) is issuing this solicitation notice to inform industry of a requirement to provide Clinical Reference Laboratory Testing Services (CRLTS). This is a follow-on requirement to the services currently being performed under contract W81K04-21-D-0001, which is set to expire on June 30, 2026. 2. REQUIREMENT DESCRIPTION The Government requires a contractor to provide comprehens...
View more3. ACQUISITION STRATEGY
The Government’s acquisition strategy is as follows: Competition: Full and Open Competition. Contract Vehicle: A single-award Indefinite Delivery/Indefinite Quantity (ID/IQ) contract. Period of Performance: A five-year base ordering period and one five-year optional ordering period, for a total potential ordering period of ten (10) years. Contract Type: Firm-Fixed-Price (FFP) task orders and/or Contract Ordering Official Card (COOC)/Government Purchase Card (GPC) orders. Source Selection Process: Performance Price Tradeoff (PPT), where non-price factors (e.g., Technical, Performance Risk, Small Business Subcontracting Participation), when combined, are significantly more important than price.
4. INCUMBENT INFORMATION
The incumbent contractor for these services is LabCorp Inc., under contract W81K04-21-D-0001.
5. CHANGES
Please note the following changes from the draft released on 6 May 2026:
6. QUESTIONS
Questions are due no later than Monday, 18 May 2026 at 12:00 p.m. Central Time. Instructions for submitting questions are provided in Exhibit B.
7. ATTACHMENTS
Please review the attached documents for full details:
RFP HT001526RE001
Attachment 1 PWS
Attachment 2 Addendum to FAR 52.212-1
Attachment 3 Addendum to FAR 52.212-2
Exhibit A – Price List
Exhibit B - Clinical Reference Laboratory Testing Services QA Matrix
Exhibit C – Past Performance Summary Sheet
Exhibit D – Past Performance Questionnaire
Exhibit E – Subcontractor Teaming Partner Letter and Table
PWS Attachment 1 -Summary of DoD Sites
PWS Attachment 2 – DD Form1423-1, System Security Plan
PWS Attachment 3 – B2B Gateway Implementation Plan and Questionnaire
PWS Attachment 4 – DHA CAC Request Process
PWS Attachment 5 – Request for Common Access Card
PWS Attachment 6 – Example of DHA Common Training
PWS Attachment 7 - DD Form 2875 System Authorization Access Request
PWS Attachment 8 – Performance Requirements Summary
PWS Attachment 9 – Deliverables